Editor profile
Chief Editor, Asia Markets
Li Wei oversees market dynamics and capital flows across major Asian economies. He focuses on regional business shifts and corporate expansion in East and Southeast Asia.
li.wei@asiabizreview.comIn the first half of 2026, Vietnam's GDP grew by 8.18%, manufacturing value-added rose by 10.23%, PMI continued to expand, and foreign-invested employment growth led the way. This article analyzes Vietnam's role and prospects in the restructuring of Asian supply chains.
Insurance technology investment in the Asia-Pacific region halved from $9.1 billion in 2018–2021 to $4.1 billion in 2022–2025, with a corresponding decline in the number of transactions. Capital flows shifted from direct-to-consumer digital insurers to technology providers and infrastructure platforms. India, Singapore, and Indonesia absorbed the majority of capital, while China’s market position declined.
Based on the IndexBox report, analyze the demand drivers, supply chain restructuring trends, and competitive landscape of the Asia-Pacific APOGEE system market, predicting a compound growth of 6.5%-8.5% from 2026 to 2035.
Based on the latest IndexBox report, the Asia-Pacific APOGEE system market is expected to achieve a CAGR of 6.5%-8.5% from 2026 to 2035, driven by industrial automation, semiconductor investment, and AI diagnostic technology. The shift of supply chains to ASEAN is reshaping the regional landscape.
Hong Kong enterprises' business confidence has declined, but nearly 80% plan to expand overseas in the next three years, with ASEAN and Mainland China as the preferred destinations, reflecting the trends of supply chain restructuring and digital transformation in Asia.
Industrial and services transaction volume in the Asia-Pacific region is expected to grow by 2% against the trend in 2026, while globally it will decline by 7%. India and Southeast Asia have become hotspots for manufacturing investment, driven by automation and AI infrastructure transactions.
A KPMG report points out that the Southeast Asian medical technology supply chain faces dual challenges of internal complexity and external regulatory fragmentation, requiring a redesign to support sustained growth.
Tariffs, the pandemic, and the energy crisis are forcing companies to abandon the "just-in-time" production model and shift toward regionalized, diversified resilient supply chains. Asia is not only the focus of rebalancing but is also reshaping its role in global manufacturing.
Against the backdrop of the EU’s continued emphasis on “de-risking,” an increasing number of European companies are choosing to stay in China, and even expand their local supply chains. What truly drives their decisions is not just cost, but a reassessment of automation, supply chain efficiency, and global delivery speed.